Moody Aldrich Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-96,237
| Closed | -$3.59M | – | 191 |
|
|
2021
Q2 | $3.59M | Sell |
96,237
-1,219
| -1% | -$45.5K | 0.5% | 80 |
|
|
2021
Q1 | $2.49M | Buy |
97,456
+1,438
| +1% | +$36.8K | 0.36% | 88 |
|
|
2020
Q4 | $2.12M | Buy |
96,018
+47
| +0% | +$1.04K | 0.34% | 89 |
|
|
2020
Q3 | $1.73M | Buy |
95,971
+2,303
| +2% | +$41.4K | 0.36% | 90 |
|
|
2020
Q2 | $2.38M | Buy |
93,668
+13,826
| +17% | +$351K | 0.51% | 77 |
|
|
2020
Q1 | $1.47M | Sell |
79,842
-119
| -0.1% | -$2.19K | 0.44% | 82 |
|
|
2019
Q4 | $1.76M | Buy |
+79,961
| New | +$1.76M | 0.36% | 92 |
|